Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association.

Change of HbA1c reporting to the new SI units.

An international consensus statement recommends that dual reporting of haemoglobin A (HbA(1c)) levels--in the current units (percentage) and Système International (SI) units (mmol/mol)--be used as an interim measure for a 2-year transition period before progressing towards the use of SI units only. This recommendation is supported by the Australasian Association of Clinical Biochemists, the Aus...

Glycohaemoglobin - a crucial measurement in modern diabetes management. Progress towards standardisation and improved precision of measurement Consensus statement from the Australian Diabetes Society, Royal College of Pathologists of Australasia and Australasian Association of Clinical Biochemists

The process of developing and validating national core competencies for diabetes educators.

The National Core Competencies for Diabetes Educators were developed on behalf of the Australian Diabetes Educators Association between July 1994 and November 1995. This paper traces the development of the competencies including the rationale for undertaking the project, the process involved and the measures taken to ensure their relevance and validity. The limitations of applying the competenc...

Simplifying the diagnosis of pulmonary embolism.

1 Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006; 12: 324-332. 2 Azziz R, Carmina E, Dewailly D, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society Guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245. 3 Teede H, Zoungas S, Hutchiso...

A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society.

Lowering blood glucose levels in people with type 2 diabetes has clear benefits for preventing microvascular complications and potential benefits for reducing macrovascular complications and death. Treatment needs to be individualised for each person with diabetes. This should start with selecting appropriate glucose and glycated haemoglobin targets, taking into account life expectancy and the ...